Page last updated: 2024-08-26

3,4-dihydroxyphenylglycol and Acute Confusional Senile Dementia

3,4-dihydroxyphenylglycol has been researched along with Acute Confusional Senile Dementia in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's2 (28.57)18.2507
2000's1 (14.29)29.6817
2010's2 (28.57)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Guimarães, J; Henriques, T; Portela Moreira, I; Vieira-Coelho, MA1
Berretta, N; Cavallucci, V; D'Amelio, M; Mercuri, NB; Nisticò, R; Nobili, A1
Ehrlich, ME; Fraser, PE; Gandy, S; Kim, SH; St George-Hyslop, PH; Westaway, D1
Goldstein, DS; Holmes, C; Kopin, IJ; Patronas, N1
Ahlskog, JE; Kokmen, E; O'Brien, JF; Petersen, RC; Tyce, GM; Uitti, RJ1
Goldstein, DS; Holmes, C; Peskind, ER; Raskind, MA1
Eisenhofer, G; Goldstein, DS; Keiser, HR; Kopin, IJ; Murphy, DL; Stull, R; Sunderland, T1

Reviews

1 review(s) available for 3,4-dihydroxyphenylglycol and Acute Confusional Senile Dementia

ArticleYear
Dysfunction of norepinephrine and its metabolites in Alzheimer's dementia - A review with meta-analysis.
    Ageing research reviews, 2023, Volume: 83

    Topics: Alzheimer Disease; Humans; Methoxyhydroxyphenylglycol; Norepinephrine

2023

Other Studies

6 other study(ies) available for 3,4-dihydroxyphenylglycol and Acute Confusional Senile Dementia

ArticleYear
Calcineurin inhibition rescues early synaptic plasticity deficits in a mouse model of Alzheimer's disease.
    Neuromolecular medicine, 2013, Volume: 15, Issue:3

    Topics: Alzheimer Disease; Animals; CA1 Region, Hippocampal; Calcineurin Inhibitors; Caspase 3; Dendrites; Disease Models, Animal; Disks Large Homolog 4 Protein; Drug Evaluation, Preclinical; Excitatory Postsynaptic Potentials; Guanylate Kinases; Long-Term Synaptic Depression; Male; Membrane Proteins; Methoxyhydroxyphenylglycol; Mice; Mice, Transgenic; Neuroprotective Agents; Phosphorylation; Phosphoserine; Post-Synaptic Density; Protein Processing, Post-Translational; Receptors, AMPA; Receptors, Metabotropic Glutamate; Tacrolimus

2013
Group II metabotropic glutamate receptor stimulation triggers production and release of Alzheimer's amyloid(beta)42 from isolated intact nerve terminals.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010, Mar-17, Volume: 30, Issue:11

    Topics: Alzheimer Disease; Amino Acids; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Humans; Methoxyhydroxyphenylglycol; Mice; Mice, Transgenic; Nerve Endings; Peptide Fragments; Receptors, Metabotropic Glutamate; Signal Transduction; Xanthenes

2010
Cerebrospinal fluid levels of catechols in patients with neurogenic orthostatic hypotension.
    Clinical science (London, England : 1979), 2003, Volume: 104, Issue:6

    Topics: Aged; Alzheimer Disease; Autonomic Nervous System Diseases; Case-Control Studies; Catechols; Chronic Disease; Humans; Hypotension, Orthostatic; Linear Models; Male; Methoxyhydroxyphenylglycol; Multiple System Atrophy; Norepinephrine

2003
Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's diseases.
    Journal of the neurological sciences, 1996, Volume: 136, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aged, 80 and over; Alzheimer Disease; Blood Platelets; Catecholamines; Epinephrine; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Norepinephrine; Parkinson Disease

1996
Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease.
    Biological psychiatry, 1999, Sep-15, Volume: 46, Issue:6

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Aged; Aging; Alzheimer Disease; Antimetabolites; Catechols; Chromatography, High Pressure Liquid; Clonidine; Cognition Disorders; Dihydroxyphenylalanine; Extracellular Space; Female; Humans; Locus Coeruleus; Male; Methoxyhydroxyphenylglycol; Neurons; Neuropsychological Tests; Norepinephrine; Yohimbine

1999
Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.
    Clinical chemistry, 1986, Volume: 32, Issue:11

    Topics: Alzheimer Disease; Animals; Catecholamines; Chromatography, Liquid; Depression; Dihydroxyphenylalanine; Dogs; Glycols; Humans; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Posture; Quality Control; Selegiline; Tranylcypromine

1986